首页> 外文期刊>Cancer Forum >Developments in melanoma management – success and failure
【24h】

Developments in melanoma management – success and failure

机译:黑色素瘤治疗的进展–成功与失败

获取原文
           

摘要

Melanoma is a high priority cancer in Australia with a lifetime risk of occurrence of 1 in 30. However the incidence rate rise is stabilising and survival now exceeds 90%. The improvements in melanoma survival are mostly based on mostly early diagnosis. The management of melanoma has gone from radical surgery to a conservative individualised approach based on new and better understandings of the biology and behaviour of the malignant melanocyte. Despite many “unknowns” and many earlier inappropriate management approaches, the outlook for melanoma patients has steadily improved over the last 50 years.
机译:黑色素瘤是澳大利亚的高度优先癌症,一生中有30分之三的终生风险。但是,发病率的上升趋势是稳定的,现在生存率超过90%。黑色素瘤生存率的提高主要基于早期诊断。黑色素瘤的治疗已从根治性手术转变为基于对恶性黑色素细胞的生物学和行为的新的更好理解的保守的个体化方法。尽管有许多“未知数”和许多较早的不合适的管理方法,但在过去的50年中,黑色素瘤患者的前景一直在稳步改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号